{"id":"W4286295706","doi":"10.1200/jco.2022.40.16_suppl.7002","title":"MOMENTUM: Phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) in symptomatic and anemic myelofibrosis (MF) patients previously treated with a JAK inhibitor.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sierra Wireless (Canada); Princess Margaret Cancer Centre","funders":"Sierra Oncology","keywords":"Medicine; Anemia; Clinical endpoint; Placebo; Myelofibrosis; Gastroenterology; Internal medicine; Randomization; Hematocrit; Ruxolitinib; Randomized controlled trial; Surgery; Urology; Bone marrow; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001269089,0.001362946,0.001710856,0.0003908678,0.0004109134,0.001273974,0.0007610074,0.00109435,0.01381579],"category_scores_gemma":[0.001447998,0.0006017949,0.001091015,0.0003879401,0.0007255538,0.0009525293,0.0004154813,0.002694502,0.001733996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007261328,"about_ca_system_score_gemma":0.00124244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001227886,"about_ca_topic_score_gemma":0.003885593,"domain_scores_codex":[0.9996908,0.0001686855,0.00001262046,0.00004510103,0.00002533558,0.00005743565],"domain_scores_gemma":[0.9994653,0.0001258017,0.0001369774,0.00003471131,0.00003057985,0.0002065364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9644808,0.008211031,0.0010324,0.0004077659,0.0006457324,0.00006080843,0.00004406324,0.0004884329,0.003358542,0.0001999203,0.003142373,0.0179283],"study_design_scores_gemma":[0.9528556,0.0429199,0.002067428,0.00003057009,0.000203428,0.00004551712,0.00002137693,0.000390544,0.0001979179,0.0001709041,0.001086695,0.0000101238],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9702113,0.00544384,0.001006044,0.001831747,0.0007357277,0.006991355,0.005331703,0.0004903543,0.007957966],"genre_scores_gemma":[0.9750079,0.002560698,0.001877881,0.002547551,0.0004733817,0.006892697,0.003624181,0.00006509984,0.006950532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01381579,"threshold_uncertainty_score":0.0462184,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06116009067063786,"score_gpt":0.4143125339813228,"score_spread":0.3531524433106849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}